Results 241 to 250 of about 483,294 (273)

SCUBE-1 as a Biomarker Predictor for the Home Follow-Up and Hospitalization of SARS-CoV-2 Patients. [PDF]

open access: yesJ Clin Med
Çanakçi SE   +8 more
europepmc   +1 more source

Immunoglobulin G and neutralizing antibody response after CoronaVac. [PDF]

open access: yesRev Assoc Med Bras (1992)
Assis PBC   +4 more
europepmc   +1 more source

SARS-CoV-2 Infection Associated with HHV-6A Reactivation and an Inhibitory KIR2DL2/HLA-C1 Immunogenetic Profile. [PDF]

open access: yesMicroorganisms
Rizzo S   +8 more
europepmc   +1 more source

Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry

open access: yes
American Journal of Hematology, Volume 101, Issue 2, Page 365-375, February 2026.
Jon Salmanton‐García   +95 more
wiley   +1 more source

Severe Acute Respiratory Syndrome (SARS) Coronavirus

Seminars in Respiratory and Critical Care Medicine, 2007
The global severe acute respiratory syndrome (SARS) outbreak was the first pandemic of the 21st century. Although the outbreak was successfully controlled, evidence that SARS emerged from an animal reservoir has raised concerns that another pandemic could occur.
Matthew P, Muller, Allison, McGeer
openaire   +2 more sources

Severe Acute Respiratory Syndrome (SARS)

2006
Udgivelsesdato ...
Sørensen, Morten Dræby   +8 more
  +5 more sources

[SARS--Severe Acute Respiratory syndrome].

Pneumologie (Stuttgart, Germany), 2003
Since November 2002 an epidemic of a new severe respiratory infection has taken place primarily in South-East Asia. Severe Acute Respiratory Syndrome (SARS) is assumed caused by a recently identified corona virus, which seems to be a new pathogen in the human population.
P, Tuschy   +6 more
  +6 more sources

Home - About - Disclaimer - Privacy